<DOC>
	<DOCNO>NCT02171026</DOCNO>
	<brief_summary>Investigation bioavailability , safety tolerability dabigatran without concomitant administration amiodarone bioavailability amiodarone desethylamiodarone administration single dose amiodarone without dabigatran</brief_summary>
	<brief_title>Bioavailability Dabigatran Amiodarone After Multiple Oral Administrations Dabigatran Etexilate With Without Amiodarone Single Dose Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>Healthy male female accord follow criterion : 1 . Based upon complete medical history , include physical examination , vital sign ( BP , pulse rate ( PR ) ) , 12lead ECG , clinical laboratory test 2 . Aged &gt; =18 &lt; =55 year 3 . Body mass index ( BMI ) &gt; =18.5 BMI &lt; =29.9 kg/m2 4 . Signed date write informed consent prior admission study accord GCP local legislation 1 . Clinically relevant gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Relevant surgery gastrointestinal tract 3 . History bleed disorder acute blood coagulation defect 4 . Diseases central nervous system , epilepsy ; psychiatric disorder neurological disorder 5 . History relevant orthostatic hypotension , faint spell blackouts 6 . Chronic relevant acute infection 7 . History allergy/hypersensitivity , include drug allergy , deem relevant study judge investigator 8 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration study 9 . Use drug , might reasonably influence result study base knowledge time protocol preparation within 10 day prior administration study 10 . Participation another study investigational drug within two month prior administration study 11 . Alcohol abuse ( 60 g/day ) 12 . Drug abuse 13 . Blood donation ; 100 mL within four week prior administration study 14 . Excessive physical activity ; within one week prior administration study 15 . Any laboratory value outside reference range clinical relevance 16 . Inability comply dietary regimen study centre 17 . Females child bear potential pregnant , breast feeding either surgically sterile sexually active use acceptable , i.e . highly effective Pearl index &gt; 1 % , form contraception either oral contraceptive since least two month double barrier method , i.e . intrauterine device spermicide condom male partner 18 . ) Male subject agree minimize risk female partner become pregnant first dose day 3 month completion poststudy medical . Acceptable method contraception comprise barrier contraception medically accept contraceptive method female partner ( intrauterine device spermicide , hormonal contraceptive since least two month ) . 19 . ) Abnormal thyroid stimulate hormone ( TSH ) screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>